PUBLICATION

Pharmaceutical Technology

AUTHORS

Ozgur Erguney, Sam Joll, Miyese Ozcan

Belgium Pharmaceuticals 2009 Pharmaceutical Technology Release

September 02, 2009

Belgium is one of the largest centers for pharmaceutical distribution and has the second highest number of pharmaceuticals exports per capita worldwide. In addition to attracting foreign companies, the country has also produced its own international heavyweights. But how will this small European country fare against its neighboring European giants and will it survive the threat of the emerging players as the global pharmaceutical industry faces turbulent times?

RELATED INTERVIEWS MORE INTERVIEWS

Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.
Piramal Pharma updates GBR in its recent developments and prospects.
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

RECENT PUBLICATIONS

Chile Mining 2025 - Digital Interactive

After navigating years of uncertainty and challenges, Chile’s mining industry has returned to peak performance.

MORE PREVIOUSLY PUBLISHED

MACIG

"Theta is fully permitted and ready to mine — financing is the final piece. With over 6 million oz of gold resources at TGME, we hold one of the largest undeveloped gold assets on the ASX."

SUBSCRIBE TO OUR NEWSLETTER